BIP Capital Partners

Skip to content
  • HOME
  • About us
    • OUR TEAM
    • OUR HISTORY
    • ESG
    • BIP IV
  • investment approach
    • INVESTMENT APPROACH
    • INVESTMENT CHARACTERISTICS
  • portfolio
    • SELECTED INVESTMENTS
    • SELECTED EXITS
  • News
  • CONTACT

Archives

Enzymotec reports 3rd quarter 2014 unaudited financial results

BIP invests in lifebrain AG, an Austrian-based medical diagnostic laboratory group

BIP sells its participation in dcinex

Pinova Capital and BIP acquire Utimaco Software AG in a buyout transaction

BIP participates in the buyout of Socotec France

Posts navigation

← Previous 1 2

BIP Capital Partners

© BIP Group Luxembourg 2025
Disclaimer